Corbus Pharmaceuticals Inc.

CRBP | NASDAQ

Price Alert Chart Builder DCF Calculator

$7.74

+$0.09 (+1.18%)

Sep 22, 2026, 10:54 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-78.54M	-40.21M	-44.6M	-42.35M	-45.64M	-111.27M
Depreciation & Amortization	-1.13M	-2.74M	641K	1.49M	1.64M	1.69M
Stock-Based Compensation	6.29M	6.15M	3.47M	5.72M	9.48M	12.46M
Other Working Capital	11.47M	-7.18M	3.07M	-3.77M	-11.36M	-798.77K
Other Non-Cash Items	-229K	585K	3.77M	1.62M	2.03M	636.05K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	9.12M	-5.58M	4.09M	-4.02M	-15.7M	-3.2M
Operating Cash Flow	-64.49M	-41.79M	-36.1M	-37.54M	-48.18M	-99.69M
Capital Expenditures	-7K	n/a	3	-13.45K	-54.17K	-484.49K
Cash Acquisitions	n/a	n/a	n/a	8.1K	n/a	n/a
Purchase of Investments	-163.09M	-180.8M	-33.88M	-86.34M	-87.27M	n/a
Sales Maturities Of Investments	161.46M	59.49M	69.53M	116.42M	13.88M	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	23.9K	n/a
Investing Cash Flow	-1.64M	-121.31M	35.64M	30.07M	-73.42M	-484.49K
Debt Repayment	n/a	-15.48M	-2.87M	-533.62K	57.78K	18.71M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	n/a	n/a	-1.82M	n/a
Financial Cash Flow	77.43M	166.58M	-2.82M	-533.62K	60.82M	154.87M
Net Cash Flow	11.29M	3.47M	-3.28M	-8M	-60.78M	54.03M
Free Cash Flow	-64.5M	-41.79M	-36.1M	-37.56M	-48.24M	-100.17M
Adj. Free Cash Flow	-70.79M	-47.94M	-39.57M	-43.28M	-57.72M	-112.63M
Maintenance CapEx	-7K	n/a	3	-13.45K	-54.17K	-484.49K
Growth CapEx	n/a	n/a	n/a	n/a	n/a	n/a
Owner Earnings	-64.5M	-41.79M	-36.1M	-37.56M	-48.24M	-100.17M